Rachel L. Nosacka - Concepedia

Author

Rachel L. Nosacka

University of Florida Health Science Center ORCID

Also Known As

Rachel L Nosacka, Rachel L. Nosacka, Rachel Nosacka

Publications

492

Citations

H-Index

Concepts

All Affiliations

University of Florida Health Science Center University of Florida University of Florida Health Florida College

About

Rachel L. Nosacka is an author at University of Florida Health Science Center specializing in medicine, cell biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	194
2	Cell Biology	5	5	194
3	Immunology	3	3	109
4	Cellular Physiology	2	2	107
5	Endocrinology	1	1	16

Rachel L. Nosacka

Publications

464

Citations

H-Index

Page 1

	Year	Citations
Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice Susan C. Kandarian, Rachel L. Nosacka, Andrea E. Delitto, Journal of Cachexia Sarcopenia and Muscle	2018	90
Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival Sarah M. Judge, Rachel L. Nosacka, Daniel Delitto, JNCI Cancer Spectrum	2018	84
IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy Chandler S. Callaway, Andrea E. Delitto, Andrew C. D’Lugos, Cancers ImmunologyPathologyImmunologic MechanismImmunotherapyCancer Biology	2019	55
MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer Sarah M. Judge, Michael R. Deyhle, Daria Neyroud, Cancer Research Skeletal Muscle ExpressionMetabolic RemodelingCancer BiologyCellular PhysiologyTumor Biology	2020	52
Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia Daniel Delitto, Sarah M. Judge, Andrea E. Delitto, Oncotarget Chemoprevention StrategyImmune RegulationImmunologyPathologyCell Death	2016	38
Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle Rachel L. Nosacka, Andrea E. Delitto, Dan Delitto, Journal of Cachexia Sarcopenia and Muscle	2020	38
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness Daria Neyroud, Rachel L. Nosacka, Chandler S. Callaway, Journal of Cachexia Sarcopenia and Muscle	2021	37
Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content Daria Neyroud, Rachel L. Nosacka, Andrew R. Judge, Journal of Muscle Research and Cell Motility Tumor BiologyOncologyColon 26Mitochondrial FunctionCancer Cachexia	2019	33
Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine Michael H. Gerber, Patrick W. Underwood, Sarah M. Judge, International Journal of Molecular Sciences	2018	21
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes Hunter S. Futch, Karen N. McFarland, Brenda D. Moore, The Journal of Experimental Medicine ImmunologyCell DeathPathologyGlucocorticoidImmunotherapy	2019	16

Page 1